Complete remission in PD-L1 high expression advanced gastric cancer patient with PD-L1 immunotherapy and chemotherapy integration treatment strategy: a case report
{{output}}
Immune checkpoint inhibitors (ICIs) have become the standard of care in treating patients with human epidermal growth factor receptor 2(HER2) negative gastric cancer, revolutionizing the treatment landscape. The combination of ICIs and chemotherapy has shown i... ...
